In addition, the MOLM16 cells contain the JAK2 V617F mutation in the JH2 pseudokinase domain of the JAK2 gene, frequently observed in MDS and myeloproliferative disorders (MPD) and has been linked to leukemogenesis [20]. This evidence concerns the gene JAK2 and myeloproliferative disorder.